Shawn Pelletier headshot

Shawn J. Pelletier

Associate Professor
Unit: School of Medicine
Department: Department of Surgery
Office location and address
Transplant Center
101 Hospital Dr
Charlottesville, Virginia 22903
Hahnemann University 1996, MD
Residency, University of Virginia School of Medicine (General Surgery)
Fellowship, University of Michigan School of Medicine (Transplant)

Shawn J. Pelletier, MD, is an associate professor in the Department of Surgery, Division of Transplantation Surgery at the University of Virginia Health System. Dr. Pelletier received his medical degree from Hahnemann University School of Medicine in Philadelphia, PA, in 1996. He completed his general surgery residency in 2003 at the University of Virginia. Dr. Pelletier went on to complete a two-year fellowship in transplantation surgery at the University of Michigan Health System, and in 2005, he joined the faculty at the University of Michigan. In 2007, he became the assistant director of the Multi-disciplinary Liver Tumor Clinic at the University of Michigan Comprehensive Cancer Center in Ann Arbor, MI. A year later, he became the surgical director of liver transplantation at the University of Michigan.

Dr. Pelletier returned to the University of Virginia in 2012 as the surgical director of liver transplantation. His clinical interests focus on living and deceased donor liver transplants, minimally invasive (laparoscopic) liver resection, as well as other aspects of hepatobiliary surgery. His research focuses on the outcomes following liver transplants and the development of donation following cardiac death.

He is board certified by the American Board of Surgery, and he is a fellow of the American College of Surgeons. Additionally, he's a member of professional and scientific societies, including the American Association for the Study of Liver Disease, the American Society of Transplant Surgeons, the International Liver Transplant Society, the International Liver Cancer Association and the American Hepato-Pancreato-Biliary Association. He is widely published in scientific and professional journals on topics related to his research and clinical experience. Dr. Pelletier has over ten years of experience as a principal investigator in basic and translational research and clinical trials. His research has been funded by the NIH/NIDDK as well as HRSA. 

International Randomized Trial to Evaluate The Effectiveness of The Portable Organ Care System (OCS¿) Liver For Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT Trial)
Source: TransMedics, Inc.
March 23, 2018 – March 31, 2026
Continued Access Protocol to Evaluate the Effectiveness of the Portable Organ Care System (OCS¿) Liver for Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT CAP)
Source: TransMedics, Inc.
October 22, 2020 – October 21, 2023
A Prospective Randomized Multi-Center Study of the Use of the LifePort® Liver Transporter (LLT) System with Vasosol® as Compared to Static Cold Storage in Orthotopic Liver Transplants
Source: Organ Recovery Systems, Inc.
August 09, 2019 – August 08, 2022
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma
Source: Target PharmaSolutions, Inc.
June 26, 2017 – June 25, 2020
MD-SURG Protocol #1241.30 BI 207127/faldaprevir combination therapy in hepatic impairment (Child-Pugh B) patients with genotype 1b chronic hepatitis C infection: HCVerso3
Source: Boehringer Ingelheim International GmbH
May 01, 2014 – May 01, 2015